SLC5A2 and type 2 diabetes mellitus: Empagliflozin (EMPA; Jardiance ®) belongs to the sodium-glucose cotransporter 2 inhibitor (SGLT2i) class of drugs used in the treatment of T2D and more recently heart failure.